Neuroregeneration Therapy Market

The neuroregeneration therapy market is experiencing steady growth, driven by the increasing global prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and spinal cord injuries. In 2023, the market was valued at US$37.0 billion, reflecting the substantial need for effective treatments for these debilitating conditions. The market is fueled by ongoing research and development efforts aimed at understanding the complex mechanisms of neurodegeneration and developing innovative therapies to promote nerve repair and regeneration. This includes advancements in areas like stem cell therapy, gene therapy, and the use of growth factors and other biological agents.